8/29/2013

The experimental weight-loss drug beloranib by Zafgen may work better than appetite-suppressing medications because it restores fat balance by prompting the body to generate less fat and burn the excesses. Trials also showed that beloranib's safety profile appeared better than those of other anti-obesity drugs, Zafgen said.

Full Story:
Reuters

Related Summaries